Patients with systemic sclerosis or Sjögren's syndrome suffer from various inflammatory reactions triggered by the body's own ...

A study led by the Barcelona Institute for Global Health (ISGlobal) in collaboration with the Clínic-IDIBAPS, has shown, for ...

Brian Gemmell, a fitness instructor, said he only had an odd swelling in his fingertips before his doctor diagnosed him with ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

New tools, treatment options, and precision medicine developments are leading to better quality of life and survival for ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...

Dr. Samuel Rosner, a thoracic oncologist at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, said a growing number of people, particularly women under 65, are ...

There are two main types of lung cancer: non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Several subtypes exist within these categories, and there are a few other ...

The study shows that these patients have distinct changes in their immune system that link to the severity of their lung damage. This discovery holds promise for developing targeted treatments for ...

Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...